Header Logo

Connection

Joan Lo to Aged

Back to Details
This is a "connection" page, showing publications Joan Lo has written about Aged.
Joan Lo
Connection Strength
2.831
Aged
  1. Examining Whether Patient Portal and Video Visit Use Differs by Race and Ethnicity Among Older Adults in a US Integrated Health Care Delivery System: Cross-Sectional Electronic Health Record and Survey-Based Study. JMIR Aging. 2024 Nov 07; 7:e63814.
    View in: PubMed
    Score: 0.112
  2. Prevalence of low vitamin D levels among older US Asian and Pacific Islander adults. Osteoporos Int. 2024 Nov; 35(11):2017-2024.
    View in: PubMed
    Score: 0.111
  3. Prevalence of sleep-related problems and risks in a community-dwelling older adult population: a cross-sectional survey-based study. BMC Public Health. 2022 11 08; 22(1):2045.
    View in: PubMed
    Score: 0.098
  4. Description of Major Osteoporotic Fractures in Women with Invasive Breast Cancer Who Received Endocrine Therapy. JAMA Netw Open. 2021 11 01; 4(11):e2133861.
    View in: PubMed
    Score: 0.091
  5. Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years. BMC Musculoskelet Disord. 2020 Dec 03; 21(1):801.
    View in: PubMed
    Score: 0.086
  6. Bone Mineral Density in Older U.S. Filipino, Chinese, Japanese, and White Women. J Am Geriatr Soc. 2020 11; 68(11):2656-2661.
    View in: PubMed
    Score: 0.085
  7. How Should We Counsel Asian Americans about Fracture Risk? J Am Geriatr Soc. 2020 07; 68(7):1613-1614.
    View in: PubMed
    Score: 0.082
  8. The Epidemiology of Metatarsal Fractures Among Older Females With Bisphosphonate Exposure. J Foot Ankle Surg. 2020 Mar - Apr; 59(2):269-273.
    View in: PubMed
    Score: 0.081
  9. Aggregation of Asian-American subgroups masks meaningful differences in health and health risks among Asian ethnicities: an electronic health record based cohort study. BMC Public Health. 2019 Nov 25; 19(1):1551.
    View in: PubMed
    Score: 0.080
  10. Atypical femur fracture incidence in women increases with duration of bisphosphonate exposure. Osteoporos Int. 2019 Dec; 30(12):2515-2520.
    View in: PubMed
    Score: 0.079
  11. Vitamin D Status Among Older Women Initiating Osteoporosis Therapy. J Am Geriatr Soc. 2019 10; 67(10):2207-2208.
    View in: PubMed
    Score: 0.078
  12. Using Pharmacy Data and Adherence to Define Long-Term Bisphosphonate Exposure in Women. J Manag Care Spec Pharm. 2019 Jun; 25(6):719-723.
    View in: PubMed
    Score: 0.077
  13. Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy. Breast Cancer Res Treat. 2018 Apr; 168(2):523-530.
    View in: PubMed
    Score: 0.070
  14. Contemporary rates and correlates of statin use and adherence in nondiabetic adults with cardiovascular risk factors: The KP CHAMP study. Am Heart J. 2017 Dec; 194:25-38.
    View in: PubMed
    Score: 0.068
  15. Predicting Adherence and Persistence with Oral Bisphosphonate Therapy in an Integrated Health Care Delivery System. J Manag Care Spec Pharm. 2017 Apr; 23(4):503-512.
    View in: PubMed
    Score: 0.066
  16. Thyroid function in end stage renal disease and effects of frequent hemodialysis. Hemodial Int. 2017 10; 21(4):534-541.
    View in: PubMed
    Score: 0.066
  17. Changing Patterns in Oral Bisphosphonate Initiation in Women between 2004 and 2012. J Am Geriatr Soc. 2017 03; 65(3):656-658.
    View in: PubMed
    Score: 0.066
  18. Applying ethnic-specific bone mineral density T-scores to Chinese women in the USA. Osteoporos Int. 2016 12; 27(12):3477-3484.
    View in: PubMed
    Score: 0.063
  19. The association of race/ethnicity and risk of atypical femur fracture among older women receiving oral bisphosphonate therapy. Bone. 2016 Apr; 85:142-7.
    View in: PubMed
    Score: 0.061
  20. Trends in mortality following hip fracture in older women. Am J Manag Care. 2015 Mar 01; 21(3):e206-14.
    View in: PubMed
    Score: 0.057
  21. Racial/ethnic differences in hip and diaphyseal femur fractures. Osteoporos Int. 2014 Sep; 25(9):2313-8.
    View in: PubMed
    Score: 0.055
  22. Clinical characteristics, bone mineral density and non-vertebral osteoporotic fracture outcomes among post-menopausal U.S. South Asian Women. Bone. 2012 Dec; 51(6):1025-8.
    View in: PubMed
    Score: 0.048
  23. Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy. Bone. 2012 Sep; 51(3):524-7.
    View in: PubMed
    Score: 0.047
  24. Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes. J Oral Maxillofac Surg. 2012 Aug; 70(8):1844-53.
    View in: PubMed
    Score: 0.047
  25. Clinical correlates of atypical femoral fracture. Bone. 2012 Jul; 51(1):181-4.
    View in: PubMed
    Score: 0.047
  26. The impact of subtrochanteric fracture criteria on hip fracture classification. Osteoporos Int. 2012 Feb; 23(2):743-50.
    View in: PubMed
    Score: 0.044
  27. Oral health considerations in older women receiving oral bisphosphonate therapy. J Am Geriatr Soc. 2011 May; 59(5):916-22.
    View in: PubMed
    Score: 0.044
  28. Fracture risk tool validation in an integrated healthcare delivery system. Am J Manag Care. 2011 Mar; 17(3):188-94.
    View in: PubMed
    Score: 0.044
  29. Radiographic findings in bisphosphonate-treated patients with stage 0 disease in the absence of bone exposure. J Oral Maxillofac Surg. 2010 Sep; 68(9):2232-40.
    View in: PubMed
    Score: 0.042
  30. Characteristics of implant failures in patients with a history of oral bisphosphonate therapy. J Oral Maxillofac Surg. 2010 Mar; 68(3):508-14.
    View in: PubMed
    Score: 0.041
  31. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg. 2010 Feb; 68(2):243-53.
    View in: PubMed
    Score: 0.039
  32. GFR, body mass index, and low high-density lipoprotein concentration in adults with and without CKD. Am J Kidney Dis. 2007 Oct; 50(4):552-8.
    View in: PubMed
    Score: 0.034
  33. Persistence with weekly alendronate therapy among postmenopausal women. Osteoporos Int. 2006; 17(6):922-8.
    View in: PubMed
    Score: 0.031
  34. Effectiveness of bisphosphonate use and risk of contralateral breast cancer and recurrence in women with early-stage breast cancer treated with tamoxifen. Breast Cancer Res Treat. 2016 Apr; 156(2):379-89.
    View in: PubMed
    Score: 0.031
  35. Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression. BMC Cancer. 2015 Apr 14; 15:278.
    View in: PubMed
    Score: 0.029
  36. Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int. 2005 Mar; 67(3):1047-52.
    View in: PubMed
    Score: 0.029
  37. Postdiagnosis alcohol consumption and breast cancer prognosis in the after breast cancer pooling project. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):32-41.
    View in: PubMed
    Score: 0.024
  38. Patient awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery system. Breast Cancer Res Treat. 2012 Sep; 135(2):591-602.
    View in: PubMed
    Score: 0.024
  39. Change in physical activity during active treatment in a prospective study of breast cancer survivors. Breast Cancer Res Treat. 2012 Jan; 131(2):679-90.
    View in: PubMed
    Score: 0.023
  40. Bisphosphonate Treatment Beyond 5 Years and Hip Fracture Risk in Older Women. JAMA Netw Open. 2020 12 01; 3(12):e2025190.
    View in: PubMed
    Score: 0.021
  41. A practical method for collecting food record data in a prospective cohort study of breast cancer survivors. Am J Epidemiol. 2010 Dec 01; 172(11):1315-23.
    View in: PubMed
    Score: 0.021
  42. Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clin Oncol. 2010 Oct 10; 28(29):4410-6.
    View in: PubMed
    Score: 0.021
  43. Quality of life among women recently diagnosed with invasive breast cancer: the Pathways Study. Breast Cancer Res Treat. 2010 Sep; 123(2):507-24.
    View in: PubMed
    Score: 0.020
  44. Determinants of Oral Bisphosphonate Use Beyond 5 Years. J Manag Care Spec Pharm. 2020 Feb; 26(2):197-202.
    View in: PubMed
    Score: 0.020
  45. Statin Therapy and Risk of Incident Diabetes Mellitus in Adults With Cardiovascular Risk Factors. Am J Cardiol. 2020 02 15; 125(4):534-541.
    View in: PubMed
    Score: 0.020
  46. Identifying Key Risk Factors for Dizziness Handicap in Middle-Aged and Older People. J Am Med Dir Assoc. 2020 03; 21(3):344-350.e2.
    View in: PubMed
    Score: 0.020
  47. The Be-Well Study: a prospective cohort study of lifestyle and genetic factors to reduce the risk of recurrence and progression of non-muscle-invasive bladder cancer. Cancer Causes Control. 2019 Feb; 30(2):187-193.
    View in: PubMed
    Score: 0.019
  48. Dietary patterns and breast cancer recurrence and survival among women with early-stage breast cancer. J Clin Oncol. 2009 Feb 20; 27(6):919-26.
    View in: PubMed
    Score: 0.019
  49. Reducing the burden of dizziness in middle-aged and older people: A multifactorial, tailored, single-blind randomized controlled trial. PLoS Med. 2018 07; 15(7):e1002620.
    View in: PubMed
    Score: 0.018
  50. Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors. Breast Cancer Res Treat. 2008 Jun; 109(3):573-9.
    View in: PubMed
    Score: 0.017
  51. NSAIDs and breast cancer recurrence in a prospective cohort study. Cancer Causes Control. 2007 Aug; 18(6):613-20.
    View in: PubMed
    Score: 0.017
  52. Patterns and reasons for switching classes of hormonal therapy among women with early-stage breast cancer. Cancer Causes Control. 2017 Jun; 28(6):557-562.
    View in: PubMed
    Score: 0.017
  53. Racial-Ethnic Differences in Fall Prevalence among Older Women: A Cross-Sectional Survey Study. BMC Geriatr. 2017 03 11; 17(1):65.
    View in: PubMed
    Score: 0.017
  54. Tailored multifactorial intervention to improve dizziness symptoms and quality of life, balance and gait in dizziness sufferers aged over 50 years: protocol for a randomised controlled trial. BMC Geriatr. 2017 02 15; 17(1):56.
    View in: PubMed
    Score: 0.016
  55. Race/ethnicity, genetic ancestry, and breast cancer-related lymphedema in the Pathways Study. Breast Cancer Res Treat. 2016 08; 159(1):119-29.
    View in: PubMed
    Score: 0.016
  56. Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population. J Am Coll Cardiol. 2016 05 10; 67(18):2118-2130.
    View in: PubMed
    Score: 0.016
  57. Retinopathy and the risk of cardiovascular disease in patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort study). Am J Cardiol. 2015 Nov 15; 116(10):1527-33.
    View in: PubMed
    Score: 0.015
  58. Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival. J Natl Cancer Inst. 2015 Jul; 107(7).
    View in: PubMed
    Score: 0.015
  59. Bone health history in breast cancer patients on aromatase inhibitors. PLoS One. 2014; 9(10):e111477.
    View in: PubMed
    Score: 0.014
  60. Retinopathy and progression of CKD: The CRIC study. Clin J Am Soc Nephrol. 2014 Jul; 9(7):1217-24.
    View in: PubMed
    Score: 0.014
  61. Increasing use of vitamin D supplementation in the chronic renal insufficiency cohort study. J Ren Nutr. 2014 May; 24(3):186-93.
    View in: PubMed
    Score: 0.013
  62. Physical performance and frailty in chronic kidney disease. Am J Nephrol. 2013; 38(4):307-15.
    View in: PubMed
    Score: 0.013
  63. FGF23 modifies the relationship between vitamin D and cardiac remodeling. Circ Heart Fail. 2013 Jul; 6(4):817-24.
    View in: PubMed
    Score: 0.013
  64. Patient-physician interaction and quality of life in recently diagnosed breast cancer patients. Breast Cancer Res Treat. 2013 Jun; 139(2):581-95.
    View in: PubMed
    Score: 0.013
  65. Treatment of vitamin D deficiency within a large integrated health care delivery system. J Manag Care Pharm. 2012 Sep; 18(7):497-505.
    View in: PubMed
    Score: 0.012
  66. Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project. Breast Cancer Res Treat. 2012 Apr; 132(2):729-39.
    View in: PubMed
    Score: 0.012
  67. Methods for assessing fracture risk prediction models: experience with FRAX in a large integrated health care delivery system. J Clin Densitom. 2011 Oct-Dec; 14(4):407-15.
    View in: PubMed
    Score: 0.011
  68. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA. 2011 Jun 15; 305(23):2432-9.
    View in: PubMed
    Score: 0.011
  69. Multivitamin use and breast cancer outcomes in women with early-stage breast cancer: the Life After Cancer Epidemiology study. Breast Cancer Res Treat. 2011 Nov; 130(1):195-205.
    View in: PubMed
    Score: 0.011
  70. Prevalence of ocular fundus pathology in patients with chronic kidney disease. Clin J Am Soc Nephrol. 2010 May; 5(5):867-73.
    View in: PubMed
    Score: 0.010
  71. Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res. 2009; 11(3):R31.
    View in: PubMed
    Score: 0.010
  72. Plasma leptin levels and coronary artery calcification in older adults. J Clin Endocrinol Metab. 2007 Feb; 92(2):729-32.
    View in: PubMed
    Score: 0.008
  73. Statin therapy and risks for death and hospitalization in chronic heart failure. JAMA. 2006 Nov 01; 296(17):2105-11.
    View in: PubMed
    Score: 0.008
  74. Value of the sagittal abdominal diameter in coronary heart disease risk assessment: cohort study in a large, multiethnic population. Am J Epidemiol. 2006 Dec 15; 164(12):1150-9.
    View in: PubMed
    Score: 0.008
  75. The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol. 2003 Jul; 14(7 Suppl 2):S148-53.
    View in: PubMed
    Score: 0.006

© 2024 Kaiser Permanente